Avid Bioservices Inc (CDMO)

[Rolodog]

Some thoughts on our next quarter:

We now know the following:

1) Revenues continue to climb at AVID
2) Cotara study is mostly complete (bleeding slows down).
3) Prostate castration study cancelled--No cash drain.
4) NSCLC 2nd line re-evualation costs completed
5) NSCLC 2nd line study mostly completed

Could we come close to break even next quarter knowing we are cutting overhead, increasing revenues and only starting 2 new studies the past 3 quarters?

Assuming there is no announcement the next few months with upfront $$$, we should continue to improve our EPS
(Currently -.04) we should approach (-.01) next quartly CC.
Looks like they are better managing their pipeline, expenses while increasing revenues.

Just some random thoughts as we wait.

Rolodog